{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T04:17:36Z","timestamp":1744085856179,"version":"3.40.3"},"reference-count":19,"publisher":"Knowledge E DMCC","issue":"2","content-domain":{"domain":["knepublishing.com"],"crossmark-restriction":true},"short-container-title":["JOVR"],"abstract":"<jats:p>Purpose: To investigate the pattern of ocular involvement in Behcet\u2019s disease (BD) with predictors of patients\u2019 final state of vision.\r\nMethods: This historical cohort encompassed the clinical records of 200 patients diagnosed according to the International Criteria for BD (ICBD), over a period of 17 years between 2004 and 2021.\r\nResults: The prevalence of Behcet\u2019s uveitis (BU) was more common in females and patients in the fourth decade of life. Ninety-five patients (47.5%) had evidence of ocular involvement in the initial ophthalmologic evaluation, and 171 patients (85.5%) manifested evidence of BU during the follow-up visits of which bilateral non-granulomatous panuveitis was the most common anatomical pattern of involvement (32.9%) followed by posterior (27.6%), anterior (26.5%), and intermediate (13.8%) uveitis. The prevalent accompanying signs were oral aphthous (67%), skin lesions (29%), and genital ulcers (19.5%). Cystoid macular edema (CME) was the most frequent ocular complication (62%), followed by cataract (57.5%) and epiretinal membranes (ERM) (36.5%). Univariate analysis showed the following determinants: male gender, younger age at onset, panuveitis, posterior uveitis, retinal vasculitis, and longer duration of uveitis as poorer visual prognostic factors of the disease. Multivariate analysis demonstrated a higher chance of poor visual prognosis of BD in patients with panuveitis, posterior uveitis, retinal vasculitis, and longer duration of uveitis.\r\nConclusion: This cohort study demonstrated an overview on epidemiological patterns of BU along with the visual prognostic factors in Iranian patients.<\/jats:p>","DOI":"10.18502\/jovr.v17i2.10796","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T07:48:10Z","timestamp":1652168890000},"page":"242-251","update-policy":"https:\/\/doi.org\/10.18502\/knecrossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Pattern and Visual Prognostic Factors of Behcet\u2019s Uveitis in Northwest Iran"],"prefix":"10.18502","volume":"17","author":[{"given":"Leila Alizadeh","family":"Ghavidel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9288-7475","authenticated-orcid":false,"given":"Masood","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farideh","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somayyeh","family":"Hazeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesam-Sadat","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7770","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Yazici H, Seyahi E, Hatemi G, Yazici Y. Beh\u00e7et syndrome: a contemporary view. Nat Rev Rheumatol 2018;14:107.","key":"125652","DOI":"10.1038\/nrrheum.2017.208"},{"doi-asserted-by":"crossref","unstructured":"\u00c7akar \u00d6zdal P. Beh\u00e7et\u2019s uveitis: current diagnostic and therapeutic approach. Turk J Ophthalmol 2020;50:169\u2013 182.","key":"125653","DOI":"10.4274\/tjo.galenos.2019.60308"},{"doi-asserted-by":"crossref","unstructured":"Khairallah M, Accorinti M, Muccioli C, Kahloun R, Kempen JH. Epidemiology of Beh\u00e7et disease. Ocul Immunol Inflamm 2012;20:324\u2013335.","key":"125654","DOI":"10.3109\/09273948.2012.723112"},{"doi-asserted-by":"crossref","unstructured":"Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, et al. HLA-B51 carriers are susceptible to ocular symptoms of Beh\u00e7et disease and the association between the two becomes stronger towards the east along the silk road: a literature survey. Ocul Immunol Inflamm 2017;25:37\u201340.","key":"125655","DOI":"10.3109\/09273948.2015.1136422"},{"doi-asserted-by":"crossref","unstructured":"Meguro A, Inoko H, Ota M, Katsuyama Y, Oka A, Okada E, et al. Genetics of Beh\u00e7et disease inside and outside the MHC. Ann Rheum Dis 2010;69:747\u2013754.","key":"125656","DOI":"10.1136\/ard.2009.108571"},{"unstructured":"Tugal-Tutkun I, Onal S, Stanford M, Akman M, Twisk JWR, Boers M, et al. An algorithm for the diagnosis of Beh\u00e7et disease uveitis in adults. Ocul Immunol Inflamm 2020;10:1\u201310.","key":"125657"},{"doi-asserted-by":"crossref","unstructured":"Bagheri M, Ahoor MH, Jafari A, Hashemi HS, Mohammadkhani M. Pattern of uveitis in Iran: a systematic review. J Ophthalmic Vis Res 2021;16:93\u2013102.","key":"125658","DOI":"10.18502\/jovr.v16i1.8255"},{"unstructured":"Ghavidel LA, Mousavi F, Bagheri M, Asghari S. Clinical course of uveitis in children in a tertiary ophthalmology center in northwest Iran. Crescent J Med Biol Sci 2017;4:200\u2013204.","key":"125659"},{"doi-asserted-by":"crossref","unstructured":"Davatchi F, Assaad-Khalil S, Calamia K, Crook J, Sadeghi- Abdollahi B, Schirmer M, et al. International team for the revision of the international criteria for Beh\u00e7et\u2019s disease (ITR-ICBD). The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014;28:338\u2013347.","key":"125660","DOI":"10.1111\/jdv.12107"},{"doi-asserted-by":"crossref","unstructured":"Standardization of Uveitis Nomenclature Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140:509\u2013516.","key":"125661","DOI":"10.1016\/j.ajo.2005.03.057"},{"doi-asserted-by":"crossref","unstructured":"Taylor SR, Singh J, Menezo V, Wakefield D, McCluskey P, Lightman S. Beh\u00e7et disease: visual prognosis and factors influencing the development of visual loss. Am J Ophthalmol 2011;152:1059\u20131066.","key":"125662","DOI":"10.1016\/j.ajo.2011.05.032"},{"doi-asserted-by":"crossref","unstructured":"Al Akrash LS, Al Semari MA, Al Harithy R. Ocular manifestations of dermatological diseases part I: infectious and inflammatory disorders. Int J Dermatol 2021;60:5\u201311.","key":"125663","DOI":"10.1111\/ijd.15101"},{"unstructured":"Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. One year in review 2018: Beh\u00e7et\u2019s syndrome. Clin Exp Rheumatol 2018;36:13\u201327.","key":"125664"},{"doi-asserted-by":"crossref","unstructured":"Amer R, Alsughayyar W, Almeida D. Pattern and causes of visual loss in Beh\u00e7et\u2019s uveitis: short-term and longterm outcomes. Graefes Arch Clin Exp Ophthalmol 2017;255:1423\u20131432.","key":"125665","DOI":"10.1007\/s00417-017-3667-0"},{"doi-asserted-by":"crossref","unstructured":"S\u00e1enz-Franc\u00e9s F, El\u00edas-de-Tejada M, Martinez-De-La- Casa J, Calvo-Gonz\u00e1lez C, Fern\u00e1ndez-Vidal A, M\u00e9ndez- Hern\u00e1ndez C, et al. Ocular inflammatory signs observed in a cohort of Spanish patients with Beh\u00e7et disease and ocular inflammation. Eur J Ophthalmol 2008;18:563\u2013566.","key":"125666","DOI":"10.1177\/112067210801800410"},{"doi-asserted-by":"crossref","unstructured":"Evereklioglu C. Current concepts in the etiology and treatment of Beh\u00e7et disease. Surv Ophthalmol 2005;50:297\u2013350.","key":"125667","DOI":"10.1016\/j.survophthal.2005.04.009"},{"doi-asserted-by":"crossref","unstructured":"Accorinti M, Pesci FR, Pirraglia MP, Abicca I, Pivetti- Pezzi P. Ocular Beh\u00e7et\u2019s disease: changing patterns over time, complications and long-term visual prognosis. Ocul Immunol Inflamm 2017;25:29\u201336.","key":"125668","DOI":"10.3109\/09273948.2015.1094095"},{"doi-asserted-by":"crossref","unstructured":"Sota J, Cantarini L, Vitale A, Sgheri A, Gentileschi S, Caggiano V, et al. Long-term outcomes of Beh\u00e7et\u2019s syndrome-related uveitis: a monocentric italian experience. Mediators Inflamm 2020;15:6872402.","key":"125669","DOI":"10.1155\/2020\/6872402"},{"doi-asserted-by":"crossref","unstructured":"Celiker H, Kazokoglu H, Direskeneli H. Factors affecting relapse and remission in Beh\u00e7et\u2019s uveitis treated with interferon Alpha2a. J Ocul Pharmacol Ther 2019;35:58\u2013 65.","key":"125670","DOI":"10.1089\/jop.2018.0083"}],"container-title":["Journal of Ophthalmic and Vision Research"],"original-title":[],"link":[{"URL":"https:\/\/knepublishing.com\/index.php\/JOVR\/article\/download\/10796\/17663","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/knepublishing.com\/index.php\/JOVR\/article\/download\/10796\/17685","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/knepublishing.com\/index.php\/JOVR\/article\/download\/10796\/17663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T10:40:33Z","timestamp":1744022433000},"score":1,"resource":{"primary":{"URL":"https:\/\/knepublishing.com\/index.php\/JOVR\/article\/view\/10796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,4,29]]}},"URL":"https:\/\/doi.org\/10.18502\/jovr.v17i2.10796","relation":{},"ISSN":["2008-322X","2008-2010"],"issn-type":[{"type":"electronic","value":"2008-322X"},{"type":"print","value":"2008-2010"}],"subject":[],"published":{"date-parts":[[2022,4,29]]}}}